WuXi Vaccines inks $3B manufacturing deal with ‘global vaccine leader’
Set to last 20 years, the contract between Wuxi and an unidentified vaccine maker calls for the Chinese CDMO to build a dedicated production plant.
Takeda CEO: It’s time to be ‘more proactive than reactive’ on outbreak prep
After prior outbreaks of Zika, Ebola, MERS and other emerging diseases left thousands dead, experts expected another crisis—it was only a matter of when. Now, amid a hunt for treatments and vaccines against the novel coronavirus, Takeda CEO Cristophe Weber says it's...